Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group
about
The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification systemPrediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosisTherapeutic options for management of endometrial hyperplasiaNew concepts for an old problem: the diagnosis of endometrial hyperplasiaReproducibility determination of WHO classification of endometrial hyperplasia/well differentiated adenocarcinoma and comparison with computerized morphometric data in curettage specimens in Iran.Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma.Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia.Hormone replacement therapy and the endometrium.Design and conduct of clinical trials in hormone replacement therapy.Nrf2 expression in endometrial serous carcinomas and its precancers.Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma.Endometrial intraepithelial neoplasia: clinical correlates and outcomes.Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.Diagnosis of premalignant endometrial disease.My approach to the interpretation of endometrial biopsies and curettings.Unexpected premalignant gynecological lesions in women undergoing vaginal hysterectomy for utero-vaginal prolapsePAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasiaDoes the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases.Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: a retrospective observational study of Taiwanese Gynecologic Oncology Group.Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.Combining endometrium sampling device and SurePath preparation to screen for endometrial carcinoma: a validation study.Effects of subdermal implants of estradiol and testosterone on the endometrium of postmenopausal women.Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.Endometrial serous carcinoma: its molecular characteristics and histology-specific treatment strategies.Diagnosing endometrial hyperplasia: why is it so difficult to agree?Management of endometrial precancers.Endometrial hyperplasia: a clinicopathological study in a tertiary care hospital.Characterization and comparison of precursors of ovarian and endometrial carcinoma: parts I and II.The role of endometrial thickness for detecting endometrial pathologies in asymptomatic postmenopausal women.Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer.Expression and clinical significance of ghrelin in endometrial hyperplasia and carcinoma of Egyptian patients.EIN and WHO94.Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: a prospective study.Supervised clustering of immunohistochemical markers to distinguish atypical and non-atypical endometrial hyperplasia.Molecular profiles of benign and (pre)malignant endometrial lesions.New classification system of endometrial hyperplasia WHO 2014 and its clinical implications.Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists.[Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study.Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses
P2860
Q24646398-7CF03C4A-0A2E-457C-8153-5C1BCE5CE0B3Q24647890-4E2D9A8C-8147-4EB7-AAC9-243036E09A41Q26783569-AE68372E-D16B-4ABA-A9FB-05FFBC7BF0ABQ28071864-8A5DCD6C-03DE-462C-86F3-6EBC0A2E04BEQ33421583-B4DE5D61-82EB-4FD4-B198-F7DE62049188Q33587348-A5DFD07A-A592-4CD7-82C0-9C54541C9CE3Q33955748-3F2E7541-91BD-434B-8F91-D8146209A0C7Q34263283-05765336-15E9-4143-97A1-FA12C9A3A9BDQ34397332-BCE0A0C6-0FBC-41DA-94D0-ECD30B97F83FQ34467239-B9AF8789-D611-46C5-B49A-E4B372E0C9A5Q35109507-5C9E87D7-E108-4113-A29E-DFB71D5D2FE5Q35164066-EB76D6CE-B6D0-4643-AD6F-5D8B54E4F084Q35187272-C81BE420-7C0F-4C0F-AA99-3BABF019FDCFQ35586140-2A81CBB3-95A9-48F4-BFE7-03D35B658D91Q35770233-F4EB1A32-AA72-477D-B834-5D619A1142CAQ36181913-760FD6BC-F673-45C0-981A-9865F96D0146Q36283995-6EBA28C9-4305-44F2-AAD7-4E44F2BD9B2FQ36493879-641FEFBE-3E4B-46CD-9CBC-9C03BCE1C27AQ36547010-C33DC71E-6D00-4BB1-AEFF-9AC775A5B712Q36608842-8F2937A8-166A-446C-89F0-EAA7DBD760C2Q36807159-59611282-DF76-4562-8011-7194A7219BA7Q36974437-8DE29B5A-6C4A-4F2B-A462-5060BDAABD9CQ36983146-247BABF5-41F0-473A-A6F7-C90F2D6D43E5Q37017041-3BC72603-31E2-4960-857E-1E1D6E74050AQ37112463-1FAA6C24-66F7-4DAC-91FB-81251A92449AQ37238537-60FC1300-9EB2-4EB6-99D0-46A5F0287069Q37468203-0EB8CD2E-F6D5-4471-8BBD-C16860884D7FQ37756401-44A1EA33-9AE8-46FF-B059-E2BFD4716C2BQ38182674-C003E210-FF28-4BA8-9164-BECB8874100AQ38589139-AF1AB897-9754-4618-A12C-ABCA41E612EEQ39617824-F7679520-3DC2-4165-9737-FFCB995BCFB1Q43010392-6E8828FE-7045-479E-A122-F027EA32C344Q46383608-E6DD14C3-A1C0-4227-93DB-9DA93A6E1135Q50616253-C936FE63-9DF7-43F8-8043-69D84376B72EQ51135997-2ABC0886-7B85-4D0A-9DFA-FDF20D02557EQ52366406-B56AC096-71AA-469B-BDCE-1F2B081E596EQ53095157-3AE43590-6878-47D1-9DF6-1ECAE194BEF3Q53279286-3EA22DC9-8C1B-4EC0-8DA3-D9C1F3158468Q53350449-08AC9F84-4C84-4D84-A308-848482611DEBQ57819009-E55BBA12-69D1-4304-9590-5ABA9F833DE6
P2860
Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Endometrial intraepithelial ne ...... ndometrial Collaborative Group
@ast
Endometrial intraepithelial ne ...... ndometrial Collaborative Group
@en
Endometrial intraepithelial ne ...... ndometrial Collaborative Group
@nl
type
label
Endometrial intraepithelial ne ...... ndometrial Collaborative Group
@ast
Endometrial intraepithelial ne ...... ndometrial Collaborative Group
@en
Endometrial intraepithelial ne ...... ndometrial Collaborative Group
@nl
prefLabel
Endometrial intraepithelial ne ...... ndometrial Collaborative Group
@ast
Endometrial intraepithelial ne ...... ndometrial Collaborative Group
@en
Endometrial intraepithelial ne ...... ndometrial Collaborative Group
@nl
P356
P1433
P1476
Endometrial intraepithelial ne ...... ndometrial Collaborative Group
@en
P2093
G L Mutter
P304
P356
10.1006/GYNO.1999.5580
P407
P577
2000-03-01T00:00:00Z